BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36461784)

  • 1. Role of perioperative chemotherapy and radiotherapy for localized high-grade malignant peripheral nerve sheath tumor at the extremities and trunk wall: a population-based cohort study.
    Kobayashi H; Zhang L; Okajima K; Hirai T; Tsuda Y; Ikegami M; Kawai A; Tanaka S
    Jpn J Clin Oncol; 2023 Jan; 53(2):138-145. PubMed ID: 36461784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiotherapy in the management of malignant peripheral nerve sheath tumors: a single-center retrospective cohort study.
    Roohani S; Claßen NM; Ehret F; Jarosch A; Dziodzio T; Flörcken A; Märdian S; Zips D; Kaul D
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17739-17747. PubMed ID: 37924493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.
    Stucky CC; Johnson KN; Gray RJ; Pockaj BA; Ocal IT; Rose PS; Wasif N
    Ann Surg Oncol; 2012 Mar; 19(3):878-85. PubMed ID: 21861229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal malignant peripheral nerve sheath tumor treated with complete surgical resection and postoperative radiation therapy.
    Mizuta Y; Kozono Y; Asai M; Sekiyama K; Yoshioka Y; Higuchi T
    J Obstet Gynaecol Res; 2024 Jan; 50(1):133-138. PubMed ID: 37844578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.
    Chowdhury A; Vivanco-Suarez J; Teferi N; Belzer A; Al-Kaylani H; Challa M; Lee S; Buatti JM; Hitchon P
    World J Surg Oncol; 2023 Oct; 21(1):338. PubMed ID: 37880773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate.
    Fetsch JF; Laskin WB; Miettinen M
    Am J Surg Pathol; 2005 Dec; 29(12):1615-24. PubMed ID: 16327434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience.
    Vauthey JN; Woodruff JM; Brennan MF
    Ann Surg Oncol; 1995 Mar; 2(2):126-31. PubMed ID: 7728565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis.
    Cai Z; Tang X; Liang H; Yang R; Yan T; Guo W
    World J Surg Oncol; 2020 Sep; 18(1):257. PubMed ID: 32998743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of intradural extension in paraspinal malignant peripheral nerve sheath tumors: effects on central nervous system metastases and overall survival.
    Gilder HE; Puffer RC; Bydon M; Spinner RJ
    J Neurosurg Spine; 2018 Dec; 29(6):725-728. PubMed ID: 30239270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant chemotherapy in patients with localized, undifferentiated pleomorphic sarcoma of soft tissue: a population-based cohort study.
    Kobayashi H; Zhang L; Hirai T; Tsuda Y; Ikegami M; Tanaka S
    Int J Clin Oncol; 2022 Apr; 27(4):802-810. PubMed ID: 35064354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant peripheral nerve sheath tumor: analysis of treatment outcome.
    Wong WW; Hirose T; Scheithauer BW; Schild SE; Gunderson LL
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):351-60. PubMed ID: 9788415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of malignant melanotic nerve sheath tumors: an institutional experience and systematic review of the literature.
    Ghaith AK; Johnson SE; El-Hajj VG; Akinduro OO; Ghanem M; De Biase G; Michaelides L; Bon Nieves A; Marsh WR; Currier BL; Atkinson JL; Spinner RJ; Bydon M
    J Neurosurg Spine; 2024 Jan; 40(1):28-37. PubMed ID: 37862711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Peripheral Nerve Sheath Tumor Arising from Small Bowel Mesentery: an Extremely Rare Case with Review of Literature.
    Zaheer S; Khosla D; Gupta V; Nada R; Kumar D; Kapoor R
    J Gastrointest Cancer; 2023 Mar; 54(1):259-263. PubMed ID: 34796455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
    Wakeman KM; Zhang QS; Bandhlish A; Cranmer LD; Ricciotti RW; Mantilla JG
    Am J Clin Oncol; 2022 Jan; 45(1):28-35. PubMed ID: 34962906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
    van Noesel MM; Orbach D; Brennan B; Kelsey A; Zanetti I; de Salvo GL; Gaze MN; Craigie RJ; McHugh K; Francotte N; Collini P; Bisogno G; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27833. PubMed ID: 31241238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.